US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 5.0700
  • -0.4200-7.65%
Close Dec 20 16:00 ET
  • 5.0700
  • 0.00000.00%
Post 20:01 ET
7.53MMarket Cap-0.50P/E (TTM)

Evoke Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.40%-818.7K
31.98%-820.62K
-58.16%-2.58M
24.42%-4.98M
55.87%-1.11M
5.39%-1.04M
12.18%-1.21M
-0.98%-1.63M
46.60%-6.6M
-25.49%-2.51M
Net income from continuing operations
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
Other non cash items
-23.85%126.03K
-23.62%124.66K
-22.56%124.66K
248.61%129.07K
-1,566.04%-360.6K
--165.5K
--163.21K
--160.96K
135.22%37.03K
--24.6K
Change In working capital
15.14%236.08K
-10.46%195.37K
-927.09%-1.38M
1,070.72%1.55M
188.69%960.26K
-62.36%205.04K
-55.72%218.19K
-6.16%166.64K
102.36%132.41K
-33.82%-1.08M
-Change in receivables
90.71%-19.52K
-63.77%-551.1K
-1,146.73%-778.83K
85.37%-48.24K
1,018.58%560.83K
32.08%-210.09K
-731.74%-336.51K
49.51%-62.47K
-21.24%-329.64K
168.66%50.14K
-Change in inventory
484.47%51.36K
129.57%44.01K
-41.66%-106.94K
-85.34%-192.46K
--23.09K
--8.79K
---148.85K
---75.49K
-595.77%-103.84K
----
-Change in prepaid assets
-7.88%227.49K
-0.04%299.92K
-21.14%222.05K
209.33%31.93K
13.24%-796.62K
-28.11%246.95K
-5.75%300.04K
23.98%281.57K
-118.53%-29.21K
-2.21%-918.18K
-Change in payables and accrued expense
-111.69%-23.25K
-8.94%402.54K
-1,277.04%-714.53K
198.67%1.89M
1,476.47%1.19M
-61.97%198.87K
264.96%442.07K
-18.18%60.71K
111.44%632.12K
-160.97%-86.19K
-Change in other current liabilities
--0
--0
--0
-248.61%-129.07K
45.64%-13.37K
-217.61%-39.47K
---38.56K
---37.68K
---37.03K
---24.6K
Cash from discontinued investing activities
Operating cash flow
21.40%-818.7K
31.98%-820.62K
-58.16%-2.58M
24.42%-4.98M
55.87%-1.11M
5.39%-1.04M
12.18%-1.21M
-0.98%-1.63M
46.60%-6.6M
-25.49%-2.51M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
2.98M
295.7K
7.54M
-101.64%-119.3K
-119.3K
0
0
0
-45.68%7.29M
0
Net common stock issuance
---191
---1
--6.72M
--0
--0
--0
--0
--0
-49.34%7.44M
2,220.40%148.99K
Proceeds from stock option exercised by employees
--3M
--295.7K
--1.25M
----
----
--0
--0
--0
----
----
Net other financing activities
---15.5K
--0
---426.29K
19.93%-119.3K
----
----
----
----
88.64%-148.99K
----
Cash from discontinued financing activities
Financing cash flow
--2.98M
--295.7K
--7.54M
-101.64%-119.3K
---119.3K
--0
--0
--0
-45.68%7.29M
--0
Net cash flow
Beginning cash position
30.99%9.18M
18.14%9.7M
-51.85%4.74M
7.64%9.84M
-51.70%5.96M
-47.91%7.01M
6.64%8.21M
7.64%9.84M
13.33%9.14M
10.84%12.35M
Current changes in cash
307.49%2.16M
56.49%-524.92K
404.33%4.96M
-830.24%-5.1M
51.11%-1.23M
5.39%-1.04M
-120.98%-1.21M
-12.98%-1.63M
-35.02%698.99K
-25.49%-2.51M
End cash Position
90.10%11.34M
30.99%9.18M
18.14%9.7M
-51.85%4.74M
-51.85%4.74M
-51.70%5.96M
-47.91%7.01M
6.64%8.21M
7.64%9.84M
7.64%9.84M
Free cash flow
21.40%-818.7K
31.98%-820.62K
-58.16%-2.58M
24.42%-4.98M
55.87%-1.11M
5.39%-1.04M
12.18%-1.21M
-0.98%-1.63M
46.60%-6.6M
-25.49%-2.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.40%-818.7K31.98%-820.62K-58.16%-2.58M24.42%-4.98M55.87%-1.11M5.39%-1.04M12.18%-1.21M-0.98%-1.63M46.60%-6.6M-25.49%-2.51M
Net income from continuing operations 22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M
Other non cash items -23.85%126.03K-23.62%124.66K-22.56%124.66K248.61%129.07K-1,566.04%-360.6K--165.5K--163.21K--160.96K135.22%37.03K--24.6K
Change In working capital 15.14%236.08K-10.46%195.37K-927.09%-1.38M1,070.72%1.55M188.69%960.26K-62.36%205.04K-55.72%218.19K-6.16%166.64K102.36%132.41K-33.82%-1.08M
-Change in receivables 90.71%-19.52K-63.77%-551.1K-1,146.73%-778.83K85.37%-48.24K1,018.58%560.83K32.08%-210.09K-731.74%-336.51K49.51%-62.47K-21.24%-329.64K168.66%50.14K
-Change in inventory 484.47%51.36K129.57%44.01K-41.66%-106.94K-85.34%-192.46K--23.09K--8.79K---148.85K---75.49K-595.77%-103.84K----
-Change in prepaid assets -7.88%227.49K-0.04%299.92K-21.14%222.05K209.33%31.93K13.24%-796.62K-28.11%246.95K-5.75%300.04K23.98%281.57K-118.53%-29.21K-2.21%-918.18K
-Change in payables and accrued expense -111.69%-23.25K-8.94%402.54K-1,277.04%-714.53K198.67%1.89M1,476.47%1.19M-61.97%198.87K264.96%442.07K-18.18%60.71K111.44%632.12K-160.97%-86.19K
-Change in other current liabilities --0--0--0-248.61%-129.07K45.64%-13.37K-217.61%-39.47K---38.56K---37.68K---37.03K---24.6K
Cash from discontinued investing activities
Operating cash flow 21.40%-818.7K31.98%-820.62K-58.16%-2.58M24.42%-4.98M55.87%-1.11M5.39%-1.04M12.18%-1.21M-0.98%-1.63M46.60%-6.6M-25.49%-2.51M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 2.98M295.7K7.54M-101.64%-119.3K-119.3K000-45.68%7.29M0
Net common stock issuance ---191---1--6.72M--0--0--0--0--0-49.34%7.44M2,220.40%148.99K
Proceeds from stock option exercised by employees --3M--295.7K--1.25M----------0--0--0--------
Net other financing activities ---15.5K--0---426.29K19.93%-119.3K----------------88.64%-148.99K----
Cash from discontinued financing activities
Financing cash flow --2.98M--295.7K--7.54M-101.64%-119.3K---119.3K--0--0--0-45.68%7.29M--0
Net cash flow
Beginning cash position 30.99%9.18M18.14%9.7M-51.85%4.74M7.64%9.84M-51.70%5.96M-47.91%7.01M6.64%8.21M7.64%9.84M13.33%9.14M10.84%12.35M
Current changes in cash 307.49%2.16M56.49%-524.92K404.33%4.96M-830.24%-5.1M51.11%-1.23M5.39%-1.04M-120.98%-1.21M-12.98%-1.63M-35.02%698.99K-25.49%-2.51M
End cash Position 90.10%11.34M30.99%9.18M18.14%9.7M-51.85%4.74M-51.85%4.74M-51.70%5.96M-47.91%7.01M6.64%8.21M7.64%9.84M7.64%9.84M
Free cash flow 21.40%-818.7K31.98%-820.62K-58.16%-2.58M24.42%-4.98M55.87%-1.11M5.39%-1.04M12.18%-1.21M-0.98%-1.63M46.60%-6.6M-25.49%-2.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List